
Preliminary Results of Immunotherapy Drug Show Promise for Mesothelioma Patients
The Meso Foundation is optimistic about the results of the Phase 1b trial of pembrolizumab for PD-L1-positive advanced solid tumors, which were announced at the
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.

The Meso Foundation is optimistic about the results of the Phase 1b trial of pembrolizumab for PD-L1-positive advanced solid tumors, which were announced at the

In 1875, Ambler, Pennsylvania was the largest manufacturer of asbestos insulation and asbestos-containing products in the United States. Asbestos manufacturing brought economic growth to Ambler.

Workers Memorial Day is a day set aside by the unions of the AFL-CIO when we honor those who have passed either on thejob or from a job

Asbestos does not always affect only the initial person exposed. Take-home exposure, also known as secondary exposure or bystander exposure, is occupational exposure carried from

Asbestos, a group of six fibrous silicate materials, is a known carcinogen,. Over the last decade, the U.S. imported over 8 million pounds of raw

Today is Day 3 of Asbestos Awareness Week. We honor this week by providing our community and the general public with educational information, blog posts,

Formerly known as the “miracle fiber,” asbestos was once used so frequently that it is estimated to have been in 3,000 different products. Today, asbestos

Two Meso Foundation supporters dedicated to mesothelioma prevention have pledged to donate up to $12,000 if we can match it. This would mean a total